1,2,3,4,6-pentakis-O-galloyl-beta-D-glucose and 2019 Novel Coronavirus Disease

1,2,3,4,6-pentakis-O-galloyl-beta-D-glucose has been researched along with 2019 Novel Coronavirus Disease in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	1 (100.00)	2.80

Authors

Authors	Studies
Chen, JC; Chen, YT; Chiou, WC; Huang, C; Hwang, LH; Lyu, YS; Yang, HY; Yang, JM	1

Other Studies

1 other study(ies) available for 1,2,3,4,6-pentakis-O-galloyl-beta-D-glucose and 2019 Novel Coronavirus Disease

Article	Year
The inhibitory effects of PGG and EGCG against the SARS-CoV-2 3C-like protease. Biochemical and biophysical research communications, 2022, 02-05, Volume: 591 Topics: Binding Sites; Catechin; Coronavirus 3C Proteases; COVID-19; Drug Evaluation, Preclinical; Humans; Hydrolyzable Tannins; Kinetics; Models, Molecular; Molecular Docking Simulation; Molecular Structure; Pandemics; Protease Inhibitors; Protein Binding; Protein Domains; SARS-CoV-2; Virus Replication	2022

Article

Year

The inhibitory effects of PGG and EGCG against the SARS-CoV-2 3C-like protease.

Biochemical and biophysical research communications, 2022, 02-05, Volume: 591

Topics: Binding Sites; Catechin; Coronavirus 3C Proteases; COVID-19; Drug Evaluation, Preclinical; Humans; Hydrolyzable Tannins; Kinetics; Models, Molecular; Molecular Docking Simulation; Molecular Structure; Pandemics; Protease Inhibitors; Protein Binding; Protein Domains; SARS-CoV-2; Virus Replication

2022